Breaking News

Your weekly roundup of STAT's First Opinion

 

First Opinion

In a week when millions of Americans were scurrying to complete and file their taxes, First Opinion authors explored undertreating pain, silence in India following a WHO warning about a "made in India" Covid-19 vaccine, why Apollo 13 and the U.S. Covid vaccination campaign can be seen as "successful failures," and more. You can read all of the week's essays here. The latest episode of the "First Opinion Podcast," on the dangerous dearth of psychiatrists, is also live.

As a pain specialist, I may have caused more harm by underprescribing opioids

By Antje M. Barreveld

Adobe

Opioids do have a place in pain control and can be safely prescribed by following best practices while monitoring for risks and side effects.

Read More

India's drug regulator has ignored red alerts on Covaxin, imperiling millions of lives

By Dinesh Thakur

Anupam Nath/AP

The WHO's warning about shoddy manufacturing processes for Covaxin should have sparked investigations by drug regulators in India. It hasn't.

Read More

The 'successful failures' of Apollo 13 and Covid-19 vaccination

By Christopher M. Worsham and Anupam B. Jena

AP

Apollo 13 astronaut James Lovell called the mission a "successful failure." That term can apply to the U.S.'s Covid-19 vaccination effort.

Read More

Amid the nation's mental health crisis, we need more psychiatrists now

By Christin Drake

Adobe

Nationwide, more applicants should gain acceptance to medical school, and training programs should boost the number of slots they offer.

Read More

FDA needs to follow through on its plan to ban carbadox in animal feed

By Harry Rhodes

BRENDAN SMIALOWSKI/AFP via Getty Images

With Robert Califf back in charge, the FDA needs to follow through on its long-stalled plan to ban the use of carbadox in animal feed.

Read More

Devastating separations continue for families seeking asylum, with dire health consequences

By Annie Leone

John Moore/Getty Images

U.S. policies to split up families compound the trauma of asylum seekers, raising the risk of harmful outcomes for mothers and babies.

Read More

STAT+: Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D

By Marc Herant and Jason Brauner

Adobe

Capturing the full value of the generic drugs that have been developed over the past few decades will require new incentive mechanisms.

Read More

The power of inclusion: Overturning the 'white wall' standard

By Sadhana Jackson

NIH

"White walls" left me with feelings of discomfort and exclusion during medical training. Diversifying portraiture makes people feel seen.

Read More

Listen: Mental health needs are soaring. Where are all the psychiatrists?

By Patrick Skerrett

This week's "First Opinion Podcast" covers the collision between the pandemic-related mental health crisis and the shortage of psychiatrists.

Read More

Sunday, April 17, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments